Clinical Trial Update: Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of rifaximin in patients with hepatosteatosis (fatty liver) and steatohepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Bezmialem Vakif University | Conditions: Fatty Liver, Steatohepatitis | NA | Status: COMPLETED